NICE draft guidance recommends siponimod for treating secondary progressive multiple sclerosis
- Oct 30, 2020
- 1 min read
NICE has today (15 October 2020) issued draft guidance which now recommends siponimod (also called Mayzent and made by Novartis) for treating secondary progressive multiple sclerosis (MS).
I am a 64 year old female, I was diagnosed of Multiple Sclerosis (MS) in 2008, my symptoms started out with severe fatigue, poor balance, numbness, double vision, heat intolerance and anxiety. I was unable to go back to work, I tried Betaseron for about 6 years. Tried every shot available, all made me sick.In November 2015, I started on Multiple Sclerosis (MS) Herbal formula from Mayaka Natural Clinic, the treatment worked incredibly for my MS condition. I used the Mayaka MS Herbal formula for a total time period of 4 months, it totally reversed my Multiple Sclerosis. I had a total decline of all symptoms including vision problems, numbness and others. Sometimes, i totally forget i ever had MS.…